Zylox-Tonbridge Medical Technology. 

€1.37
0
+€0+0% Tuesday 08:15

Statistik

Dagens högsta
1.39
Dagens lägsta
1.37
52V högsta
-
52V lägsta
-
Volym
0
Genomsnittlig volym
-
Marknadsvärde
448M
P/E förhållande
137
Utdelningsavkastning
-
Utdelning
-

Kommande

Inkomster

19AugFörväntad
Q4 2023
Q2 2024
0.03
0.36
0.69
1.03
Förväntad EPS
Ej tillämpligt
Verklig EPS
0.026368274575

Människor följer också

Den här listan baseras på bevakningslistorna för människor på Stock Events som följer 818.F. Det är inte en investeringsrekommendation.

Konkurrenter

Denna lista är en analys baserad på nyliga marknadshändelser. Det är inte en investeringsrekommendation.

Om

Zylox-Tonbridge Medical Technology Co., Ltd., a medical device company, provides neuro- and peripheral-vascular interventional medical devices the People's Republic of China and internationally. The company develops neurovascular product portfolio that covers a suite of products for various categories, including ischemic stroke, hemorrhagic stroke, intracranial stenosis, carotid artery, and intracranial access devices. It also develops peripheral-vascular interventional product portfolio covering a spectrum of arterial and venous products comprising stents, balloons, catheters, and filters, as well as covers hemodialysis access, aortic intervention, peripheral embolization intervention, and radiological intervention products. In addition, the company provides technical consultation and services, as well as imports materials. The company was formerly known as Zhejiang Zylox Medical Device Co., Ltd. and changed its name to Zylox-Tonbridge Medical Technology Co., Ltd. in March 2021. Zylox-Tonbridge Medical Technology Co., Ltd. was incorporated in 2012 and is headquartered in Hangzhou, the People's Republic of China.
Show more...
VD
Dr. Zhong Zhao
Anställda
756
Land
CN
ISIN
CNE100004JD2
WKN
000A3CS7H

Noteringar